Straumann Holding AG · SIX:STMN

Straumann — Goldman Sachs Healthcare Conference 2014

10 slides from Straumann's conference presentation, Sep 4, 2014

1. Slide 1: Becoming a solution provider of choice in premium & value

   01.09.2014 Becoming a solution provider of choice in premium & value Thomas Dressendörfer, CFO Goldman Sachs Healthcare conference London, 4 September 2014 0 Strong financial and strategic progress REVENUE BEST PERFORMERS GROSS MARGIN CHF 359m APAC & ROW 78.9% H1: +5% (organic) +1.6% points (excl. F

2. Slide 2: Fifth consecutive quarter of above-market growth

   01.09.2014 Fifth consecutive quarter of above-market growth Rightsizing and Q2: revenue of re-organisation CHF 179mn (+3% in l.c.) measures 2014 guidance Easter effect 1 * Straumann, Nobel Biocare, Zimmer Dental, Biomet 3i, Dentsply Implants - based on company and SEC 1Straumann, Nobel Biocare, Zimm

3. Slide 3: Covering the remaining white spots

   01.09.2014 Covering the remaining white spots Roxolid/SLActive New ceramic 4mm implant implant BLT implant & enhance Surgeons / Prosthodontists screw-retained prosthetics High-tech Ceramic implants Smaller, less Fixed invasive immediate implants edentulous GPs solutions Implants for narrow spaces Es

4. Slide 4: Straumann's comprehensive implant portfolio

   01.09.2014 Straumann’s comprehensive implant portfolio Shorter/ More primary Aesthetics thinner stability Q1 2015 4mm short PURE Tissue Level Bone Level Bone Level Tapered2 implant Monotype SLA SLActive SLActive SLA SLActive SLA SLActive ZLA Titanium1    Roxolid        Ceramic  1 Commerc

5. Slide 5: Substantial investments in dynamic Asian markets

   01.09.2014 Substantial investments in dynamic Asian markets China (BJFM) MegaGen Biodenta Corp. DM Capital Korea, international Taiwan/Switzerland, Location China China presence international presence CHF 6m Consideration up CHF 18m convertible Investment +2m convertible CHF 5m to CHF 27m bonds (3%

6. Slide 6: Global presence in the value segment

   01.09.2014 Global presence in the value segment Europe1 NAM LATAM APAC Implants Implant systems Standard prosthetics CADCAM Abutments Abutments for 3rd party implants Bars/bridges for 3rd party implants 10 1 Selected countries Outlook for the year 2014 guidance 11 11§§§ 6

7. Slide 7: Calendar of upcoming events

   01.09.2014 Calendar of upcoming events 2014 04 September Goldman Sachs Healthcare conference London 05 September Investor meetings London 15 September Investor meetings Frankfurt 23 October Third‐quarter results Webcast 20 November Credit Suisse Swiss Midcap conference Zurich 03 December Berenberg E

8. Slide 8: Pressure to adapt to market trends

   01.09.2014 Pressure to adapt to market trends General practitioner (GP) segment gaining importance with different needs than the specialists segments Female dentists becoming more and more important Value players gaining share on behalf of premium players Young dentist with different needs when it c

9. Slide 9: Organization adapted to match market development

   01.09.2014 Organization adapted to match market development Global worforce (period‐end)  Headcount reduced by 300 to pre- 2517 economic crisis level 2452 2361 2313  Overall restructuring/downsizing costs in 2278 2201 2170 2217 2013 amount to a net CHF 8m1  Strong, engaged team of professionals r

10. Slide 10: EBIT margin clears 20% threshold

    01.09.2014 EBIT margin clears 20% threshold In % of revenue, rounded +420 bps 2.6% 0.0% 1.6% (0.9%) 1.6% 16.7% 20.9% 16.0% Reported H1 FX effect Restructuring Adjusted H1 Gross margin OPEX reduction Other income Reported H1 EBIT costs1 EBIT improvement EBIT 2013 2014 20 20 1 Exceptional costs of CHF

Straumann — Goldman Sachs Healthcare Conference 2014 on 6ix